Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40 subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through engagement of a novel receptor (IL-23R) on these cells. Recent analysis of the contribution of IL-12 and IL-23 to central nervous system autoimmune inflammation demonstrated that IL-23 rather than IL-12 was the essential cytokine. Using gene-targeted mice lacking only IL-12 (p35−/−) or IL-23 (p19−/−), we show that the specific absence of IL-23 is protective, whereas loss of IL-12 exacerbates collagen-induced arthritis. IL-23 gene-targeted mice did not develop clinical signs of disease and were completely resistant to the development of joint and bone pathology. Resistance correlated with an absence of IL-17–producing CD4+ T cells despite normal induction of collagen-specific, interferon-γ–producing T helper 1 cells. In contrast, IL-12–deficient p35−/− mice developed more IL-17–producing CD4+ T cells, as well as elevated mRNA expression of proinflammatory tumor necrosis factor, IL-1β, IL-6, and IL-17 in affected tissues of diseased mice. The data presented here indicate that IL-23 is an essential promoter of end-stage joint autoimmune inflammation, whereas IL-12 paradoxically mediates protection from autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5. A model proposing the respective roles of IL-12/IFN-γ and IL-23 in T cell-priming events versus end-stage autoimmune inflammation. The precise mechanism through which IL-12/IFN-γ may down-regulate the magnitude of the inflammatory response (i.e., reducing IL-17 production) remains to be defined. It is recognized that IFN-γ may have dual roles during late-stage inflammation (i.e., antiinflammatory actions through termination of activated T cell responses [references 9, 29] while also stimulating macrophage function [reference 5]). a, The IL-23R is present on CD4+ CD45RBlo “memory” T cells (30), but this cell phenotype may also include activated CD4+ T cells that are not strictly memory T cells.](https://figures.cochat.ai/paper-figures/7aaa8df7955d4b7f85c0b7ac367626a2/divergent-pro-and-antiinflammatory-roles-for-il-23-and-il-12-in-joint-autoimmune-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Th17 cells, originally described in mice as being pathogenic in murine models of autoimmune disease [181, 182], have more recently been shown to protect against certain pathogens, including fungal infections [183].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Self-citationRapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., & Ramshaw, I. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3223 · Cited by 635
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580 · cited 1×
“IL-17 is a potent proinflammatory cytokine produced by PBMCs/T cells and by cells isolated from synovial fluid of rheumatoid arthritis patients (27).”
BackgroundAccelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Cited by
Items 801–900 of 1,001
Gao, J., Kong, R., Zhou, X., Ji, L., Zhang, J., & Zhao, D. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1474-7 · Cited by 43
Najar, M., Fayyad‐Kazan, H., Faour, W. H., Merimi, M., Sokal, E. M., Lombard, C. A., & Fahmi, H. (2018) · Inflammation Research · doi:10.1007/s00011-018-1205-0 · Cited by 49
Th17 cells: A new paradigm for cutaneous inflammation
Asarch, A., Barak, O. G., Loo, D. S., & Gottlieb, A. B. (2008) · Journal of Dermatological Treatment · doi:10.1080/09546630802206686 · Cited by 46
Zhu, L., Wu, Y. R., Wei, H., Xing, X., Zhan, N., Xiong, H., & Peng, B. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.11.008 · Cited by 45
Lombardelli, L., Logiodice, F., Aguerre‐Girr, M., Kullolli, O., Haller, H., Casart, Y. C., Berrebi, A., L’Faqihi-Olive, F.-E., Duplan-Eche, V., Romagnani, S., et al. (2016) · Clinical and Molecular Allergy · doi:10.1186/s12948-016-0039-y · Cited by 44
Therapeutic potential of targeting IL‐17 and IL‐23 in sepsis
Bosmann, M., & Ward, P. A. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-4 · Cited by 42
“Later stages of Th17 cell differentiation (clonal expansion, phenotype stabilization with IL-17 production) also rely on expression of IL-23, which is a potent inducer of IL-17 [12,13].”
BackgroundIL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
Li, H., & Tsokos, G. C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08823-4 · Cited by 48
The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease
Mannion, J. M., McLoughlin, R. M., & Lalor, S. J. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08928-y · Cited by 43
Induction of Th17 differentiation by corneal epithelial‐derived cytokines
Zheng, X., Bian, F., Ma, P., de Paiva, C. S., Stern, M. E., Pflugfelder, S. C., & Li, D. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21926 · Cited by 42
Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease
Rasouli, M., Heidari, B., & Kalani, M. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.09.017 · Cited by 46
Koenders, M. I., & van den Berg, W. B. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04039.x · Cited by 42
Wang, J. M., Shi, L., Cheng, J., Xiao, J., Ying, R. S., Wu, X. Y., Wang, K. S., Li, G., Moorman, J. P., & Yao, Z. Q. (2013) · Journal of Virology · doi:10.1128/jvi.03376-12 · Cited by 47
Contreras-López, R. A., Figueroa, F. E., Djouad, F., & Luz‐Crawford, P. (2016) · Stem Cells International · doi:10.1155/2016/3162743 · Cited by 45
Kalim, K. W., & Groettrup, M. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.08.014 · Cited by 43
Role of caveolin-1 in the regulation of the vascular shear stress response
Frank, P. G., & Lisanti, M. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28509 · Cited by 55
Stepwise Regulation of TH1 Responses in Autoimmunity: Il-12-Related Cytokines and Their Receptors
Becker, C., Wirtz, S. J., & Neurath, M. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000172808.03877.4d · Cited by 51
The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
Peerlings, D. E. M., Mimpen, M., & Damoiseaux, J. G. M. C. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100123 · Cited by 48
IL-17A and IL-17F Expression in B Lymphocytes
Vazquez‐Tello, A., Halwani, R., Li, R., Nadigel, J., Bar-Or, A., Mazer, B. D., Eidelman, D. H., Al‐Muhsen, S., & Hamid, Q. A. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000329527 · Cited by 46
Behrends, J., Renauld, J., Ehlers, S., & Hölscher, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057379 · Cited by 50
Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis
Li, R., Zheng, X., Popov, I., Zhang, X., Wang, H., Suzuki, M., de Necochea-Campion, R., French, P. W., Chen, D., Siu, L. K. S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-19 · Cited by 41
Does systemic inflammation and immune activation contribute to fracture risk in HIV?
McGinty, T., Mirmonsef, P., Mallon, P. W. G., & LANDAY, A. L. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000275 · Cited by 45
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
Atzeni, F., Carriero, A., Boccassini, L., & D’Angelo, S. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s259126 · Cited by 44
IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity
Fukuda (2010) · International Journal of Oncology · doi:10.3892/ijo_00000620 · Cited by 43
Annunziato, F., Cosmi, L., & Romagnani, S. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833647c2 · Cited by 47
Tiriveedhi, V., Takenaka, M., Ramachandran, S., Gelman, A. E., Subramanian, V., Patterson, G. A., & Mohanakumar, T. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04191.x · Cited by 40
Saito, Y., Kagami, S., Sanayama, Y., Ikeda, K., Suto, A., Kashiwakuma, D., Furuta, S., Iwamoto, I., Nonaka, K., Ohara, O., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38324 · Cited by 40
Chemokine Receptors in T-Cell-Mediated Diseases of the Skin
Lonsdorf, A. S., Hwang, S. T., & Enk, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.122 · Cited by 47
Omrane, I., Baroudi, O., Bougatef, K., Mézlini, A., Abidi, A., Medimegh, I., Stambouli, N., Ayari, H., Kourda, N., Uhrhammer, N. A., et al. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.002 · Cited by 42
Jadon, D. R., Tillett, W. L., Wallis, D., Cavill, C., Bowes, J., Waldron, N., Dixon, A., Sengupta, R., Barton, A. C., Korendowych, E., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes254 · Cited by 40
Kotloski, N. J., Nardelli, D. T., Peterson, S. H., Torrealba, J. R., WARNER, T. F. C. S., Callister, S. M., & Schell, R. F. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00129-08 · Cited by 40
Park, S. Y., Gupta, D., Hurwich, R., Kim, C. H., & Dziarski, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101068 · Cited by 44
Viperin controls chikungunya virus–specific pathogenic T cell IFNγ Th1 stimulation in mice
Carissimo, G., Teo, T., Chan, Y., Lee, C. Y., Lee, B. T. K., Torres‐Ruesta, A., Tan, J. J. L., Chua, T., Fong, S., Lum, F., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900298 · Cited by 40
Intrahepatic TH17/TReg Cells in Homeostasis and Disease—It’s All About the Balance
Drescher, H. K., Bartsch, L. M., Weiskirchen, S., & Weiskirchen, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.588436 · Cited by 47
Interleukin-17 gene expression in patients with rheumatoid arthritis
Kohno, M., Tsutsumi, A., Matsui, H., Sugihara, M., Suzuki, T., Mamura, M., Goto, D., Matsumoto, I., Ito, S., Suguro, T., et al. (2007) · Modern Rheumatology · doi:10.1007/s10165-007-0015-y · Cited by 42
IL‐15 exacerbates collagen‐induced arthritis with an enhanced CD4+ T cell response to produce IL‐17
Yoshihara, K., Yamada, H., Hori, A., Yajima, T., Kubo, C., & Yoshikai, Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737229 · Cited by 41
Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6
Rong, Z., Cheng, L., Ren, Y., Li, Z., Li, Y., Li, X., Li, H., Fu, X.-Y., & Chang, Z. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.025 · Cited by 40
Eaton, K. A., Benson, L. H., Haeger, J., & Gray, B. M. (2006) · Infection and Immunity · doi:10.1128/iai.01887-05 · Cited by 42
Cornelissen, F., Asmawidjaja, P. S., Mus, A. M. C., Corneth, O. B. J., Kikly, K. K., & Lubberts, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057553 · Cited by 48
Interleukin 17–producing T helper cells in alloimmunity
Benghiat, F. S., Charbonnier, L., Vokaer, B., Wilde, V. D., & Moine, A. L. (2008) · Transplantation Reviews · doi:10.1016/j.trre.2008.08.007 · Cited by 44
Sukhov, A., Adamopoulos, I. E., & Maverakis, E. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8529-8 · Cited by 43
Immune regulation and B-cell depletion therapy in patients with primary Sjögren’s syndrome
Abdulahad, W. H., Kroese, F. G. M., Vissink, A., & Bootsma, H. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.01.009 · Cited by 41
New advances in juvenile idiopathic arthritis
Huang, J. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106171 · Cited by 44
CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-κB pathway in dendritic cells
Kuwabara, T., Tanaka, Y., Ishikawa, F., Kondo, M., Sekiya, H., & Kakiuchi, T. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811415 · Cited by 41
Yu, R. Y.-L., & Gallagher, G. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002410 · Cited by 45
IL-17 and related cytokines involved in systemic sclerosis: Perspectives
Gonçalves, R. S. G., Pereira, M. C., Dantas, A. T., de Almeida, A. R., Marques, C. D. L., Rêgo, M. J. B. D. M., Pitta, I. D. R., Duarte, Â. L. B. P., & Pitta, M. G. D. R. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1416467 · Cited by 42
Sweet, K., Song, Q., Loza, M. J., McInnes, I. B., Ma, K., Leander, K. R., Lakshminarayanan, V., Franks, C. F., Cooper, P. R., & Siebert, S. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001679 · Cited by 39
The inflammatory Th 17 subset in immunity against self and non-self antigens
Jin, D., Zhang, L., Zheng, J., & Zhao, Y. L. (2008) · Autoimmunity · doi:10.1080/08916930701776605 · Cited by 48
Type 3 cytokines in liver fibrosis and liver cancer
Molina, M. F., Abdelnabi, M. N., Fabre, T., & Shoukry, N. H. (2019) · Cytokine · doi:10.1016/j.cyto.2018.07.028 · Cited by 39
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
Cui, X., Liu, W., Jiang, H., Zhao, Q., Hu, Y., Tang, X., Liu, X., Dai, H., Rui, H., & Liu, B. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100263 · Cited by 48
Park, M.-J., Park, H.-S., Oh, H.-J., Lim, J.-Y., Yoon, B. Y., Kim, H., Cho, M., & Cho, S. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.11.078 · Cited by 39
Active immunization against IL-23p19 improves experimental arthritis
Ratsimandresy, R. A., Duvallet, E., Assier, É., Semerano, L., Delavallée, L., Bessis, N., Zagury, J., & Boissier, M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.134 · Cited by 43
IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema
Fujii, U., Miyahara, N., Taniguchi, A., Waseda, K., Morichika, D., Kurimoto, E., 古賀, 光., Kataoka, M., Gelfand, E. W., Cua, D. J., et al. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0015oc · Cited by 39
Self-citationInterleukin-23 as a therapeutic target for inflammatory myopathy
Umezawa, N., Kawahata, K., Mizoguchi, F., Kimura, N., Yoshihashi‐Nakazato, Y., Miyasaka, N., & Kohsaka, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-23539-4 · Cited by 41
Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet’s disease
Lew, W., Chang, J., Jung, J. Y., & Bang, D. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08403.x · Cited by 38
Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T‐helper 17 cells
Kamiyama, T., Watanabe, H., Iijima, M., Miyazaki, A., & Iwamoto, S. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01544.x · Cited by 39
Kageyama, Y., Kobayashi, H., & Kato, N. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0217-6 · Cited by 39
Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia
Saitoh, T., Tsukamoto, N., Koiso, H., Mitsui, T., Yokohama, A., Handa, H., Karasawa, M., Ogawara, H., Nojima, Y., & Murakami, H. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01651.x · Cited by 43
Jia, R., Tang, M., Qiu, L., Sun, R., Cheng, L., Ma, X., Yin, G., Hu, G., Wang, X., & Zhao, Y. F. (2014) · Pancreas · doi:10.1097/mpa.0000000000000284 · Cited by 38
The regulatory mechanism and potential application of IL-23 in autoimmune diseases
Xiong, D.-K., Shi, X., Han, M., Zhang, X., Wu, N.-N., Sheng, X.-Y., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.982238 · Cited by 45
Utsugi, M., Dobashi, K., Ishizuka, T., Kawata, T., Hisada, T., Shimizu, Y., Ono, A., & Mori, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4550 · Cited by 41
Pineda, M. A., Al‐Riyami, L., Harnett, W., & Harnett, M. M. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12252 · Cited by 44
Ustekinumab Associated With Flares of Psoriatic Arthritis
Stamell, E. F., Kutner, A. J., Viola, K. V., & Cohen, S. R. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5728 · Cited by 37
Influence of molecular genetics in Vogt-Koyanagi-Harada disease
Ng, J. Y., Luk, F. O. J., Lai, T. Y. Y., & Pang, C. (2014) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-014-0020-1 · Cited by 38
Razawy, W., van Driel, M., & Lubberts, E. (2018) · European Journal of Immunology · doi:10.1002/eji.201646787 · Cited by 41
Huang, X., Shentu, H., He, Y., Lai, H., Chen, X., Chen, M., & Zhu, H. (2023) · Immunologic Research · doi:10.1007/s12026-023-09366-4 · Cited by 37
Zimmerman, D. H., Taylor, P., Bendele, A. M., Carambula, R. E., Duzant, Y., Lowe, V., O’Neill, S. P., Talor, E., & Rosenthal, K. S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.016 · Cited by 40
Garden of therapeutic delights: new targets in rheumatic diseases
Waldburger, J., & Firestein, G. S. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2556 · Cited by 43
Interleukin-17A Increases Neurite Outgrowth from Adult Postganglionic Sympathetic Neurons
Chisholm, S. P., Cervi, A. L., Nagpal, S., & Lomax, A. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5343-11.2012 · Cited by 42
Rheumatoid arthritis: ‘melting pot’ of T helper subsets
Vyas, S., Hansda, A. K., & Goswami, R. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1621865 · Cited by 41
Liu, J., Xiang, Z., & Ma, X. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1184 · Cited by 46
PGE2 Elevates IL‐23 Production in Human Dendritic Cells via a cAMP Dependent Pathway
Shi, Q., Yin, Z., Zhao, B., Sun, F., Yu, H., Yin, X., Zhang, L., & Wang, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/984690 · Cited by 36
Álvarez, Y., Rodríguez, M. R., Municio, C., Hugo, E., Alonso, S., Ibarrola, N., Fernández, N., & Crespo, M. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391839 · Cited by 39
PPAR γ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?
da Rocha, L. F., Dantas, A. T., Duarte, Â. L. B. P., Rêgo, M. J. B. D. M., Pitta, I. D. R., & Pitta, M. G. D. R. (2013) · PPAR Research · doi:10.1155/2013/519724 · Cited by 37
Prevosto, C., GOODALL, J. C., & Gaston, H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120208 · Cited by 40
Maroof, A., & Kaye, P. M. (2007) · Infection and Immunity · doi:10.1128/iai.00643-07 · Cited by 36
Plasticity within the αβ+CD4+T-cell lineage: when, how and what for?
Coomes, S. M., Pelly, V. S., & Wilson, M. S. (2013) · Open Biology · doi:10.1098/rsob.120157 · Cited by 51
Xu, W., Xie, Q., Zhao, Y., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep18584 · Cited by 39
Velázquez, F., Grodecki‐Pena, A., Knapp, A., Salvador, A. M., Nevers, T. A., Croce, K., & Alcaide, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501171 · Cited by 36
The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU)
Sun, D., Liang, D., Kaplan, H. J., & Shao, H. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.017 · Cited by 36
Lawlor, K. E., Wong, P. K. K., Campbell, I. K., van Rooijen, N., & Wicks, I. P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21495 · Cited by 40
Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization
McAleer, J. P., Liu, B., Li, Z., Ngoi, S., Dai, J., Oft, M., & Vella, A. T. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909631 · Cited by 39
IL-23/IL-17 Biology and Therapeutic Considerations
Dong, C. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910801897953 · Cited by 38
Sönmez, C., Yücel, A. A., Yeşil, T. H., Küçük, H., Sezgin, B., Mercan, R., Yücel, E., & Demirel, G. Y. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4049-7 · Cited by 36
Kai, H., Shibuya, K., Wang, Y., Kameta, H., Kameyama, T., Tahara‐Hanaoka, S., Miyamoto, A., Honda, S., Matsumoto, I., Kôyama, A., et al. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02361.x · Cited by 36
Update on the role of Interleukin 17 in rheumatologic autoimmune diseases
Konya, C., Paz, Z., Apostolidis, S. A., & Tsokos, G. C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.003 · Cited by 35
Review: T helper 17 cells: Their role in glomerulonephritis
Ooi, J. D., Kitching, A. R., & Holdsworth, S. R. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01343.x · Cited by 40
Wen, T., Li, Y., Wu, M., Sun, X., Bao, X., Lin, Y., Hao, J., Han, L., Cao, G., Wang, Z., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34528 · Cited by 37
IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysis
Peng, L.-L., Wang, Y., Zhu, F.-L., Xu, W., Ji, X.-L., & Ni, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13607 · Cited by 35
miR-155 indicates the fate of CD4+ T cells
Chen, L., Gao, D., Shao, Z., Zheng, Q., & Yu, Q. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.05.003 · Cited by 40
The Role of Creatine in the Development and Activation of Immune Responses
Bredahl, E. C., Eckerson, J. M., Tracy, S., McDonald, T. L., & Drescher, K. M. (2021) · Nutrients · doi:10.3390/nu13030751 · Cited by 41
Park, M., Park, J., Park, E., Lim, M., Kim, S., Lee, D., Baek, S.-Y., Yang, E., Woo, J., Lee, J. J., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38313 · Cited by 36
Julià, A., Moore, J., Miquel, L., Alegre, C., Barceló, P., Ritchie, M., & Marsal, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.03.011 · Cited by 35
Regulatory effects of C5a on IL-17A, IL-17F, and IL-23
Grailer, J. J., Bosmann, M., & Ward, P. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00387 · Cited by 36
VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells
Guo, X., Zhang, Y., Wang, P., Li, T., Fu, W., Mo, X., Shi, T., Zhang, Z., Chen, Y., Ma, D., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.07.009 · Cited by 35
Self-citationImmune Derangements in Patients with Myelofibrosis: The Role of Treg, Th17, and sIL2Rα
Wang, J. C. C., Sindhu, H., Chen, C., Kundra, A., Kafeel, M. I., Wong, C., & Lichter, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116723 · Cited by 36
Stamp, L. K., Easson, A., Lehnigk, U., Highton, J., & Hessian, P. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23455 · Cited by 36
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease.
Ferrante, A., Ciccia, F., Principato, A., Giardina, A. R., Impastato, R., Peralta, S., & Triolo, G. (2010) · Clinical and Experimental Rheumatology · Cited by 40
Zhu, L., Wu, Y. R., Wei, H., Yang, S., Zhan, N., Xing, X., & Peng, B. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.016 · Cited by 35
Liu, Y., Rui, X.-X., Shi, H., Qiu, Y., & Peng, Y.-P. (2018) · Medical Science Monitor · doi:10.12659/msm.906184 · Cited by 38
Regeneration of Damaged Tendon-Bone Junctions (Entheses)—TAK1 as a Potential Node Factor
Friese, N., Gierschner, M. B., Schadzek, P., Roger, Y., & Hoffmann, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155177 · Cited by 40
Metadata
- Authors
- Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J.
- Affiliations
- 1Discovery Research, DNAX Research Inc., Palo Alto, CA 94304
- 2Experimental Pathology and Pharmacology, DNAX Research Inc., Palo Alto, CA 94304
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-12-08
- Volume
- 198
- Issue
- 12
- Pages
- 1951-1957
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194162
- OpenAlex
- W2116828514
- Cited by
- 1,669
- References
- 32
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 27 · 2023: 31 · 2022: 34 · 2021: 42 · 2020: 46 · 2019: 53 · 2018: 53 · 2017: 56 · 2016: 55 · 2015: 76 · 2014: 75 · 2013: 98 · 2012: 105
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-23, IL-12, collagen-induced arthritis, IL-17-producing T cells, CD4+ T cells, Th1 cells, IL23R, bone pathology, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, IL-17
- MeSH terms
- Animals, Arthritis, Experimental, Female, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, T-Lymphocytes, Tumor Necrosis Factor-alpha, Interleukin-12, Interleukin-17, Collagen Type II, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.